RxDoctor Payments Data

Paul Watkins

Gastroenterology · Chapel Hill, NCNPI 1386705366

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $859,120 of the $876,203 with a category attached, or 98.1%. It is spread thinly across 60 manufacturers, the largest accounting for just 11.5%. Among gastroenterology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$876,203in general payments, 2019–2025

Across 262 payments — averaging $3344.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intercept Pharmaceuticals, Inc.$101K
  • Pfizer$83K
  • Mirum Pharmaceuticals, Inc.$55K
  • Janssen Research & Development, LLC$51K
  • Actelion Pharmaceuticals, Ltd$49K
  • Takeda Pharmaceuticals U.S.A., Inc.$47K
  • plus $490K from 54 others
$195,949in research payments, 2019–2025

Across 15 payments — averaging $13,063 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$172K
  • AbbVie$15K
  • Boehringer Ingelheim International GmbH$8K

What the payments were for

  • Consulting fees$859,12098%
  • Speaking & faculty fees$6,9501%
  • Travel & lodging$8,3771%
  • Food & beverage$1,7560%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intercept Pharmaceuticals, Inc.8$100,947
Pfizer27$83,222
Mirum Pharmaceuticals, Inc.3$54,925
Janssen Research & Development, LLC16$50,675
Actelion Pharmaceuticals, Ltd5$48,850
Takeda Pharmaceuticals U.S.A., Inc.8$47,119
Merck5$43,473
AbbVie(2 entities)18$28,044
Sarepta Therapeutics, Inc.15$27,645
Bayer11$24,848
GW Research Limited2$24,400
F. Hoffmann-la Roche AG11$21,836
Biohaven Pharmaceuticals, Inc.3$19,963
Jazz Pharmaceuticals Inc.16$19,578
HRA Pharma7$19,247
UCB SA2$19,013
Biogen7$18,558
Spark Therapeutics, Inc.13$18,240
Astellas Pharma Global Development3$14,788
Sanofi3$12,402
Amgen4$10,681
Daiichi Sankyo Inc.6$10,613
Servier Bioinnovation2$10,400
Acorda Therapeutics, Inc7$9,801
Eli Lilly1$9,450
Gilead4$8,448
Bristol Myers Squibb4$8,320
PTC Therapeutics, Inc.4$8,125
Alnylam Pharmaceuticals Inc.3$7,395
Geron Corporation3$7,000
UCB Biosciences Inc.2$6,500
Ferring International Pharmascience Center US1$6,439
Xeris Pharmaceuticals, Inc.2$6,375
Novo Nordisk1$6,000
E.r. Squibb & Sons, L.L.C.1$5,688
Alkermes, Inc.2$4,800
Sanofi US Services Inc.2$3,944
Blueprint Medicines Corporation1$3,876
EMD Serono, Inc.2$3,750
Myovant Sciences GmbH1$3,589
Akebia Therapeutics Inc1$3,413
Novo Nordisk Health Care AG1$3,375
Sage Therapeutics, LLC2$3,348
Agios Pharmaceuticals, Inc.2$3,000
Novartis Pharma AG1$2,275
Biohaven Pharmaceutical Holding Company Ltd.1$2,275
Greenwich Biosciences, Inc.1$2,000
Boehringer Ingelheim International GmbH1$1,950
CSL Behring1$1,875
Mitsubishi Tanabe Pharma Development America, Inc.2$1,788
Acadia Pharmaceuticals Inc2$1,650
Grifols, S.A.2$1,625
Exelixis Inc.1$1,625
Seagen Inc.1$1,138
Novartis1$1,000
Genentech, Inc.1$1,000
Almirall LLC1$1,000
Biomarin Pharmaceutical Inc.1$1,000
Strongbridge US Inc.1$750
Boehringer Ingelheim1$655

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$876,203 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina →

Other gastroenterology in Chapel Hill

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →